Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
January, the Biden administration released its proposed Medicare Advantage rates in 2026. These are the rates that the ...
Medicare is big business, recently providing healthcare coverage to 68 million people. It changes a little or a lot every ...
The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
New bill introduced to stop 2.83% Medicare physician pay cut and provide 2% pay bump to stabilize practices and protect patient access to care.
To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback